KOVERA LABS · CLIENT RECORD·SNAPSHOT 2026-08-02
MAXXED: 5 Kovera certificates.
The lab's record shows 5 certificates printed for MAXXED, analysed between 22 Apr 2026 and 23 Apr 2026, covering 5 products. Median HPLC purity is 99.85%. Kovera graded 5 as a pass and 0 as a fail.
5
certificates
99.85%
median purity
5
products
0
lab verdict: fail
0
failure rules met
What the record shows
RETRIEVED 2 AUGUST 2026None of the 5 certificates meets our failure rules: no lab fail, no unconfirmed identity, no purity under 95% and no content under 90% of the label. 3 measured more than 110% of the label, which Kovera does not grade as a fail.
A certificate covers the sample the client sent, and the client decides which results go public. The figures are as published on 2 August 2026; check the lab's verify page for the current version before you rely on one.
Products tested
5 AS PRINTEDBPC-157/TB-500 · 1CJC-1295 (No DAC)/Ipamorelin · 1GHK-Cu · 1Retatrutide · 1Tirzepatide · 1
Every certificate
NEWEST FIRST · 5 ROWS| Report | Product | Lot | Purity | % of label | Analysed | Result | Check |
|---|---|---|---|---|---|---|---|
| KVR-2026-44BBF1 | CJC-1295 (No DAC)/Ipamorelin | B260410 | 99.814% | 112.8%11.28 of 10 mg | 23 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-3E409D | GHK-Cu | B260410 | 99.982% | 108.6%54.31 of 50 mg | 23 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-24D131 | Tirzepatide | B260410 | 99.899% | 108.9%32.67 of 30 mg | 23 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-038167 | BPC-157/TB-500 | B260410 | 99.678% | 113.5%11.35 of 10 mg | 23 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-13DE5C | Retatrutide | B260410 | 99.848% | 114.9%11.49 of 10 mg | 22 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |